HOUSTON — A retrospective study presented at the Society of Hematologic Oncology (SOHO) 2025 suggested that glucagon-like peptide-1 receptor agonists (GLP-1s) such as semaglutide (Ozempic/Wegovy) — ...
Modulation of neutrophil gelatinase-associated lipocalin2 (NGAL, oncogene 24/p3), proinflammatory cytokines (PIC), cystatin C and lipid rafts disruption (LR) with HMG-CoA reductase inhibitor ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback